We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+5.12%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.05B
AUM Growth
-$355M
(-5.5%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36
Top Buys
| 1 |
GeneDx Holdings
WGS
|
+$41.9M |
| 2 |
Generac Holdings
GNRC
|
+$40.9M |
| 3 |
Vaxcyte
PCVX
|
+$24.8M |
| 4 |
Teradyne
TER
|
+$24.8M |
| 5 |
UL Solutions
ULS
|
+$21.1M |
Top Sells
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$64.4M |
| 2 |
GE Vernova
GEV
|
+$42.1M |
| 3 |
Inspire Medical Systems
INSP
|
+$40.6M |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$37.8M |
| 5 |
Lithia Motors
LAD
|
+$33.8M |
Sector Composition
| 1 | Healthcare | 39.12% |
| 2 | Industrials | 19.41% |
| 3 | Technology | 15.63% |
| 4 | Energy | 7.14% |
| 5 | Consumer Discretionary | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intuitive Surgical
ISRG
$139B
| $27.6M | 0.46% |
59,942
+551
| +0.9% | +$279K |
|
77
MSCI
MSCI
$44.2B
| $27.5M | 0.45% |
51,068
+14,788
| +41% | +$8.34M |
|
78
Baker Hughes
BKR
$57.2B
| $26.7M | 0.44% |
438,017
+88,043
| +25% | +$5.09M |
|
|
MBX
79
MBX Biosciences
MBX
$2.7B
| $26.6M | 0.44% |
890,000
| – | – |
|
|
CNTA
80
DELISTED
Centessa Pharmaceuticals
CNTA
| $26.5M | 0.44% |
+668,142
| New | +$17.1M |
|
|
SION
81
Sionna Therapeutics
SION
$2.01B
| $25.9M | 0.43% |
645,530
+6,485
| +1% | +$247K |
|
82
Frontdoor
FTDR
$5.3B
| $25.7M | 0.43% |
486,232
+1,071
| +0.2% | +$63.9K |
|
83
EQT Corp
EQT
$31.3B
| $25.5M | 0.42% |
399,975
-9,632
| -2% | -$564K |
|
84
SiTime
SITM
$18.7B
| $25.4M | 0.42% |
73,665
-82,318
| -53% | -$30.3M |
|
85
Revolution Medicines
RVMD
$40B
| $25.4M | 0.42% |
261,425
-116,836
| -31% | -$11.8M |
|
86
Disc Medicine
IRON
$2.92B
| $25.3M | 0.42% |
395,572
+180
| +0% | +$12.5K |
|
87
CG Oncology
CGON
$6.44B
| $25M | 0.41% |
369,985
+57,540
| +18% | +$3.26M |
|
88
WEC Energy
WEC
$37.8B
| $24.2M | 0.4% |
209,072
+2,355
| +1% | +$265K |
|
89
Vertiv
VRT
$119B
| $23.8M | 0.39% |
95,010
-10,989
| -10% | -$2.44M |
|
90
Immix Biopharma
IMMX
$783M
| $23.2M | 0.38% |
2,549,019
| – | – |
|
91
Arrowhead Research
ARWR
$10.5B
| $23.2M | 0.38% |
370,000
| – | – |
|
92
International Paper
IP
$19.3B
| $23M | 0.38% |
645,438
-80,782
| -11% | -$3.36M |
|
|
93
UL Solutions
ULS
$18.1B
| $22.8M | 0.38% |
+267,774
| New | +$21.1M |
|
94
Motorola Solutions
MSI
$69B
| $22.8M | 0.38% |
52,581
-21,448
| -29% | -$9.29M |
|
95
Sherwin-Williams
SHW
$82B
| $22.8M | 0.38% |
71,124
+520
| +0.7% | +$179K |
|
96
Pentair
PNR
$12.5B
| $22.5M | 0.37% |
259,595
-66,685
| -20% | -$6.53M |
|
97
Halliburton
HAL
$29.6B
| $22.2M | 0.37% |
568,546
+503,202
| +770% | +$17.4M |
|
98
Constellation Energy
CEG
$93.5B
| $22.1M | 0.37% |
78,108
+4,072
| +6% | +$1.24M |
|
99
Ovid Therapeutics
OVID
$452M
| $22M | 0.36% |
9,916,911
+5,631,911
| +131% | +$10.1M |
|
100
ADC Therapeutics
ADCT
$158M
| $21.4M | 0.35% |
5,701,655
+2,337,588
| +69% | +$9.22M |
|
Similar funds
AWA
HPG
CDDEC
EMPI
RCG
WHRC
GA
JWBC